Skip to main content
Fig. 6 | Molecular Neurodegeneration

Fig. 6

From: Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay

Fig. 6

Non-specific markers of neurodegeneration and Protein DJ1 as a marker for Parkinson’s disease. Graphs a-d show the results of the targeted proteomic multiplexed assay of protein biomarkers quantitated in the CSF of control, Lewy body dementia, Parkinson’s and Alzheimer’s disease. Graphs a-c show biomarkers that show significant changes in all disease groups compared to controls. Protein DJ1 (d) shows only a significant change in Parkinson’s disease compared to controls. * Denotes new biomarkers not described previously

Back to article page

Molecular Neurodegeneration

ISSN: 1750-1326